Saudi patient with peroxisome biogenesis disorder with novel variant: a case report
- 1 January 2021
- journal article
- Published by Discover STM Publishing Ltd. in Journal of Biochemical and Clinical Genetics
Abstract
Background: Peroxisomes are cells\' organelles that responsible for the metabolism of branched-chain and very-long-chain fatty acids (VLCFA), polyamines, and amino acids. Peroxisomal biogenesis factor 6 (PEX6) is one of the factors required for the import of the proteins into peroxisomes. Mutation in any one of PEX genes will result in Zellweger syndrome (ZS), one of the peroxisome biogenesis disorder. Case Presentation: A 11-year-old girl referred was with central hypotonia and global developmental delay and feeding problems. She has an open and flat fontanel. Liver function tests and thyroid-stimulating hormone were elevated. Plasma VLCFA C26, VLCFA C24/C22, and VLCFA C26/C22 were elevated. Cerebrospinal fluid flow artifact and posterior displacement of the basilar artery findings raised the possibility of increased intracranial pressure. X-ray showed mild irregularity in the end plates of the lumbar vertebrae, bilateral coxa valga, irregularity in the articular surfaces of the ossified epiphysis of the upper and lower limbs, and generalized osteopenia. The audiological assessment profound hearing loss in both ears. Inborn error of metabolism, next-generation sequencing gene panel analysis, and whole exome sequencing showed that no pathogenic or likely pathogenic variants explaining the phenotypes. The single nucleotide polymorphisms testing showed a deletion in PEX6 gene (homozygous variant of uncertain significance). Conclusion: We report a case of ZS associated with a new PEX6 mutation that has not been previously reported in the literature.This publication has 11 references indexed in Scilit:
- Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicityJournal of Applied Genetics, 2017
- Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case reportJournal of Medical Case Reports, 2017
- Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelinesMolecular Genetics and Metabolism, 2015
- Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorderHuman Mutation, 2010
- Spectrum ofPEX6mutations in Zellweger syndrome spectrum patientsHuman Mutation, 2009
- Reactive oxygen species and peroxisomes: Struggling for balanceBioFactors, 2009
- Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disordersHuman Mutation, 2009
- PeroxisomeDB: a database for the peroxisomal proteome, functional genomics and diseaseNucleic Acids Research, 2006
- The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrumMolecular Genetics and Metabolism, 2004
- Disruption of a PEX1–PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum diseaseProceedings of the National Academy of Sciences of the United States of America, 1998